In conclusion, NPR family members can affect tumor progression by regulating fatty acid oxidation, metabolic reprogramming, and chemotherapy resistance, and their potential as prognostic markers (e.g., NPRA positively correlates with gastric cancer stage) and molecular imaging targets (NPRC-mediated imaging of prostate cancer) has been initially demonstrated. The gene discussed is NPR3; the disease is Familial prostate cancer.